PatientGain Launches HIPAA-Compliant Marketing For TMS, Ketamine and Spravato Clinics

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

The official launch of the company's new PLATINUM service to provide clients with an all-in-one, fully managed, HIPAA-compliant digital marketing engine.

-- PatientGain has officially launched its PLATINUM service, an all-in-one, fully managed, HIPAA-compliant digital marketing engine engineered specifically for clinics offering advanced mental health treatments. The platform provides comprehensive marketing solutions for specialized clinics delivering neuroplasticity-based treatments, including Transcranial Magnetic Stimulation (TMS), IV Ketamine, and Spravato, with pricing starting at $1699/month.

Specialized mental health clinics face unique hurdles, including strict regulatory compliance, patient education barriers, and a heavy reliance on a steady pipeline of professional medical referrals. PatientGain's PLATINUM tier directly addresses these industry pain points by pairing healthcare-trained AI agents with expert human project managers and oversight. This hybrid approach ensures that sensitive healthcare marketing campaigns are both highly effective and HIPAA compliant.

"Marketing for cutting-edge treatments like TMS, Ketamine, and Spravato requires a delicate balance of patient education, local medical networking, and strict adherence to healthcare privacy laws," said Sarah Clark, spokesperson for PatientGain. "The PLATINUM tier functions as a complete digital marketing solution that handles the heavy lifting-from educating prospective patients to sending 3 monthly Email campaigns-while maintaining HIPAA and regulatory protection."

Key features of the PatientGain PLATINUM service for specialized Ketamine and Spravato clinics include:

  • HIPAA Compliance & Legal Protection: All marketing systems and patient intake pathways operate under a comprehensive Business Associate Agreement (BAA) to protect patient privacy.
  • Digital Marketing Strategy: Advanced direct-to-consumer (DTC) digital campaigns combined with AI enabled strategies targeting local patients.
  • AI-Powered Patient Education: Healthcare-trained AI agents that handle initial inquiries, however HITL (Human-In-The-Loop) delivers information about advanced neuroplasticity treatments, and streamline lead conversions.
  • Human Managed Oversight: Expert human project managers who monitor, optimize, campaigns to match the local demographics and specific clinical offerings of each partner clinic.

The PLATINUM service is available immediately for medical groups and independent clinics looking to scale their patient acquisition safely and effectively.

For more information about PatientGain use the contact details below:

Contact Info:
Name: PatientGain Team
Email: Send Email
Organization: PatientGain
Website: http://www.patientgain.com

Release ID: 89203469

If there are any deficiencies, problems, or concerns regarding the information presented in this press release that require attention or if you need assistance with a press release takedown, we encourage you to notify us without delay at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our diligent team is committed to promptly addressing your concerns within 8 hours and taking necessary actions to rectify any identified issues or facilitate the removal process. Providing accurate and trustworthy information is of utmost importance.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  255.09
-3.36 (-1.30%)
AAPL  339.57
+0.59 (0.17%)
AMD  624.01
+8.49 (1.38%)
BAC  56.22
-1.74 (-3.00%)
GOOG  347.39
-3.48 (-0.99%)
META  736.14
-5.10 (-0.69%)
MSFT  497.99
-3.62 (-0.72%)
NVDA  228.95
+1.57 (0.69%)
ORCL  148.94
+0.38 (0.26%)
TSLA  379.33
+4.03 (1.07%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.